Cargando…

Clinical factors associated with hepatitis B screening and vaccination in high-risk adults

BACKGROUND: Hepatitis B virus is a viral infection that can lead to acute and/or chronic liver disease, and hepatocellular carcinoma (HCC). Hepatitis B vaccination is 95% effective in preventing infection and the development of chronic liver disease and HCC due to hepatitis B. In 2011, the Centers f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayoola, Rotimi, Larion, Sebastian, Poppers, David M, Williams, Renee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354120/ https://www.ncbi.nlm.nih.gov/pubmed/30705721 http://dx.doi.org/10.4254/wjh.v11.i1.86

Ejemplares similares

Risk factors for de novo hepatitis B during solid cancer treatment
por: Sugimoto, Rie, et al.
Publicado: (2020)

Validation of the PAGE-B score to predict hepatocellular carcinoma risk in caucasian chronic hepatitis B patients on treatment
por: Gokcen, Pinar, et al.
Publicado: (2022)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations
por: Huang, Bi-Xia, et al.
Publicado: (2020)

Risk factors analysis of prognosis of adult acute severe myocarditis
por: Zhang, Qian, et al.
Publicado: (2020)

Risk factors for preoperative carcinogenesis of bile duct cysts in adults
por: Wu, Xin, et al.
Publicado: (2021)

Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B
por: Hu, Yan-Chao, et al.
Publicado: (2017)

Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area
por: Lauar, Isabela Dias, et al.
Publicado: (2021)

Risk factors for ribavirin treatment failure in Asian organ transplant recipients with chronic hepatitis E infection
por: Low, En Xian Sarah, et al.
Publicado: (2019)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

High levels of serum interleukin-6 increase mortality of hepatitis B virus-associated acute-on-chronic liver failure
por: Zhou, Chao, et al.
Publicado: (2020)

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
por: Murata, Ayato, et al.
Publicado: (2016)

Incidence of infectious complications is associated with a high mortality in patients with hepatitis B virus-related acute-on-chronic liver failure
por: Wang, Chen, et al.
Publicado: (2019)

Perinatal transmission in infants of mothers with chronic hepatitis B in California
por: Burgis, Jennifer C, et al.
Publicado: (2017)

Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021)

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
por: Ayoub, Fares, et al.
Publicado: (2018)

Decreased of BAFF-R expression and B cells maturation in patients with hepatitis B virus-related hepatocellular carcinoma
por: Khlaiphuengsin, Apichaya, et al.
Publicado: (2020)

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
por: Lovett, Grace C, et al.
Publicado: (2017)

Identification of independent risk factors for intraoperative gastroesophageal reflux in adult patients undergoing general anesthesia
por: Zhao, Xiao, et al.
Publicado: (2021)

Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study
por: Chen, Yu-Jung, et al.
Publicado: (2017)

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Occult hepatitis B virus infection and surgical outcomes in non-B, non-C patients with curative resection for hepatocellular carcinoma
por: Koga, Hiroki, et al.
Publicado: (2017)

Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease
por: Zeng, Jing, et al.
Publicado: (2020)

IFIT1 polymorphisms predict interferon-α treatment efficiency for hepatitis B virus infection
por: Xie, Dong-Ying, et al.
Publicado: (2016)

Serum vitamin D and vitamin-D-binding protein levels in children with chronic hepatitis B
por: Huang, Cai-Zhi, et al.
Publicado: (2021)

Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection
por: Wang, Ming-Fang, et al.
Publicado: (2021)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B
por: Wang, Rui, et al.
Publicado: (2023)

Performance evaluation of NeuMoDx 96 system for hepatitis B and C viral load
por: Chooramani, Gagan, et al.
Publicado: (2023)

Evaluation of high-risk factors and the diagnostic value of alpha-fetoprotein in the stratification of primary liver cancer
por: Jiao, Hong-Bin, et al.
Publicado: (2022)

Retrospective study of the associations between hepatitis C virus infection and metabolic factors
por: Yair-Sabag, Shira, et al.
Publicado: (2016)

Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus
por: Wu, Meng-Jiao, et al.
Publicado: (2021)

Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus
por: Domagalski, Krzysztof, et al.
Publicado: (2016)

Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B
por: Chi, Xiu-Mei, et al.
Publicado: (2021)

Effects of different intervention methods on psychological flexibility, negative emotions and sleep quality in chronic hepatitis B
por: Zheng, Ying, et al.
Publicado: (2023)

Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B
por: Wang, Lin, et al.
Publicado: (2018)

Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Li, Tai-Ping, et al.
Publicado: (2019)

Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis
por: Xu, Shi-Hao, et al.
Publicado: (2020)

Clinical efficacy of antiviral therapy in patients with hepatitis B-related cirrhosis after transjugular intrahepatic portosystemic shunt
por: Yao, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dfqjnc0qtibigce9f7fufq8sko